Brian Van Ness
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 52
- Multiple Myeloma Research and Treatments 50
-
- Protein Degradation and Inhibitors 13
- Glycosylation and Glycoproteins Research 11
- Co-authors
- Daniel D. Billadeau (13 shared papers)Martin M. Oken (17 shared papers)Philip R. Greipp (12 shared papers)Robert A. Kyle (14 shared papers)Neil E. Kay (15 shared papers)Rafaël Fonseca (6 shared papers)Patricia T. Greipp (6 shared papers)David Harrington (4 shared papers)
- Journals
- Blood (23 papers)Leukemia (9 papers)Nucleic Acids Research (5 papers)The Journal of Law Medicine & Ethics (4 papers)British Journal of Haematology (3 papers)
- Partner nations
- United StatesFrancePoland
In The Last Decade
Brian Van Ness
88 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 107
- Hematology 2.5k
- Genetics 561
- Oncology 1.2k
- Molecular Biology 2.2k
- Immunology 548
Countries citing papers authored by Brian Van Ness
This map shows the geographic impact of Brian Van Ness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Van Ness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Van Ness more than expected).
Fields of papers citing papers by Brian Van Ness
This network shows the impact of papers produced by Brian Van Ness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Van Ness. The network helps show where Brian Van Ness may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Van Ness, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 479 | |
| 2 | 2002 | 251 | |
| 3 | 1993 | 206 | |
| 4 | 1996 | 182 | |
| 5 | 1998 | 158 | |
| 6 | 1992 | 153 | |
| 7 | Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study. | 2002 | 147 |
| 8 | 2005 | 133 | |
| 9 | 1991 | 122 | |
| 10 | 2001 | 109 | |
| 11 | 1996 | 93 | |
| 12 | 1996 | 93 | |
| 13 | Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6. | 1995 | 89 |
| 14 | 2004 | 83 | |
| 15 | 2011 | 79 | |
| 16 | 2015 | 79 | |
| 17 | 2019 | 76 | |
| 18 | 2000 | 61 | |
| 19 | 2015 | 61 | |
| 20 | 2006 | 60 |
About Brian Van Ness
Brian Van Ness is a scholar working on Hematology, Molecular Biology, Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 88 papers that have together received 4.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (50 papers), T-cell and B-cell Immunology (16 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Protein Degradation and Inhibitors (13 papers), Glycosylation and Glycoproteins Research (11 papers), Chronic Lymphocytic Leukemia Research (11 papers), Peptidase Inhibition and Analysis (7 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Hematology (2.5k citations), Genetics (561 citations), Oncology (1.2k citations), Molecular Biology (2.2k citations) and Immunology (548 citations). Brian Van Ness has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Daniel D. Billadeau, Martin M. Oken, Philip R. Greipp, Robert A. Kyle, Neil E. Kay, Rafaël Fonseca, Patricia T. Greipp, David Harrington, Traci Leong and Emily Blood. Their work appears in journals such as Blood, Leukemia, Nucleic Acids Research, The Journal of Law Medicine & Ethics and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.